Trial intelligence / Profile preview

Low-dose vasopressin vs phenylephrine to prevent cardiopulmonary bypass-induced vasoplegic syndrome in CABG surgery

IRCT201408201127N2Phase 3Completed

Sponsor
Research Deputy of Tabriz University of Medical Sciences
Start
Sep 2014
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 3 trial of vasopressin and phenylephrine in Vasoplegia (2 arms), sponsored by Research Deputy of Tabriz University of Medical Sciences. Started Sep 2014; status: completed.

02

Drugs

vasopressinphenylephrine
03

Conditions

Vasoplegia

Beyond the preview

Go deeper on IRCT201408201127N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201408201127N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call